Browse Submissions By Project

TaqMan Drug Metabolism SNP Genotyping Assays
Principal Investigator: Xiaoqing You

Autonomic Pharmacodynamic Pharmacogenomics
Principal Investigator: Daniel T. O'Connor

Beta Adrenergic Receptor Genotypes and Asthma
Principal Investigator: Richard Judson

Common Adverse Drug Reactions
Principal Investigator: Dr. Maryellen de Mars

Pharmacogenetics of CYP Inhibition and Activation
Principal Investigator: Timothy Scott Tracy

Consortium on Breast Cancer Pharmacogenomics
Principal Investigator: David A. Flockhart

Linking Collagen Genotypes to Molecular Phenotypes
Principal Investigator: Teri E. Klein

Functional Polymorphism Analysis in Drug Pathways
Principal Investigator: Howard Lawrence McLeod

GEC-NI
Principal Investigator: Dr. Francesca Bosetti

Genetic Epidemiology of Responses to Antihypertensives
Principal Investigator: Stephen T. Turner, M.D.

Genetics of Folate Modulation of Phenotype
Principal Investigator: Alexander S. Whitehead

Genetics of Opioid Induced Hyperalgesia
Principal Investigator: David Clark

Predictors of Anticoagulation Control on Warfarin
Principal Investigator: Dr. Stephen E Kimmel

INternational VErapamil-trandolapril STudy
Principal Investigator: Julie A. Johnson

International Tamoxifen Pharmacogenomics Consortium

International Warfarin Pharmacogenetics Consortium

The linkage disequilibrium maps of three human chromosomes across four populations
Principal Investigator: Dr. Francisco M De La Vega

Molecular Genetics of Human Behavior
Principal Investigator: Charles Glatt

Pharmacogenetics of NAT and Sulfonamide Toxicity
Principal Investigator: Craig Karl Svensson

Niemann-Pick C1-like 1
Principal Investigator: Dr. Jason S Simon

Non-Network / Other

Pharmacogenetics of Anticancer Agents - University of Chicago
Principal Investigator: Mark J. Ratain

Pharmacogenetics of Asthma Monotherapy
Principal Investigator: John Joseph Lima PharmD

The Amish Pharmacogenomics of Anti-Platelet Intervention Study
Principal Investigator: Dr. Alan Rodney Shuldiner

Pharmacogenomics and Risk of Cardiovascular Disease
Principal Investigator: Ronald M. Krauss

Pharmacogenomics of Arrhythmia Therapy
Principal Investigator: Dan Mark Roden

Pharmacogenetics, Biomarkers, and Antithrombotic Therapy
Principal Investigator: Brian F. Gage

Pharmacogenetics and Cardiovascular Events
Principal Investigator: Dr. Bruce M Psaty

Pharmacogenomic Evaluation of Antihypertensive
Principal Investigator: Julie A. Johnson

Pharmacogenetics of FMO
Principal Investigator: Ronald N. Hines

Pharmacogenetics of the Statin Response
Principal Investigator: Dr. Ernst John Schaefer

Pharmacogenetics of Asthma Treatment
Principal Investigator: Scott T. Weiss

Pharmacogenetics of Asthma Treatment/Pharmacogenetics of Asthma Monotherapy
Principal Investigator: John Joseph Lima PharmD

Pharmacodynamics of the mu Opioid Receptor
Principal Investigator: Mary Jeanne Kreek

Personalized Medicine Research Project
Principal Investigator: Dr. Michael DeFoix Caldwell

Pharmacogenetics of Membrane Transporters
Principal Investigator: Kathleen M. Giacomini

Pharmacogenetics of Nicotine Addiction Treatment
Principal Investigator: Dr. caryn lerman

Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Principal Investigator: Richard M. Weinshilboum

UCLA Pharmacogenetics and Pharmacogenomics Research Group
Principal Investigator: Julio Licinio

Pharmacogenetics of Human Reductases
Principal Investigator: Dr. Javier Guillermo Blanco

Relative Impact of SNPs and Covariates
Principal Investigator: Russell Alan Wilke

Genetics of schizophrenia, bipolar disorder and alcoholism
Principal Investigator: Dr. Hugh Malcolm Gurling

Pharmacogenetics of Acute Lymphoblastic Leukemia
Principal Investigator: Maja Krajinovic